Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
Condition(s):Renal Cell Carcinoma; Renal Cancer; Renal Cancer MetastaticLast Updated:April 19, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma; Renal Cancer; Renal Cancer MetastaticLast Updated:April 19, 2023Recruiting
Condition(s):Advanced Kidney CancerLast Updated:August 8, 2022Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 15, 2023Recruiting
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:March 23, 2023Recruiting
Condition(s):Metastatic Clear Cell Renal Cell CarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Metastatic Renal Cell Carcinoma; Stage IV Renal Cell Cancer AJCC v8Last Updated:March 12, 2024Recruiting
Condition(s):Oligometastatic Renal Cell CarcinomaLast Updated:August 30, 2023Recruiting
Condition(s):Kidney CancerLast Updated:February 11, 2020Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; VHL SyndromeLast Updated:March 7, 2024Recruiting
Condition(s):Renal Tumor; Renal CancerLast Updated:October 7, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.